FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

J&J chief turns down pay raise

Tools

Behind Door No. 2 in executive compensation land, we find Johnson & Johnson CEO Bill Weldon (photo). The scoop lies within a filing with the Securities and Exchange Commission, but in this case it's not the sort of arrangement a company seeks to hide--especially not now, when the economy is in a recession and layoffs are the order of the day (J&J laid off some 5,000 folks in 2007).

The news? Weldon turned down a merit-pay increase in his base salary for 2009. The compensation committee had offered him the increase, but Weldon recommended that his base salary remain at $1.8 million "in recognition of the current global economic environment," the AP reports. For 2008 he'll reap a $3.5 million bonus, 85 percent of that in cash.

- read the AP story
- see the article in the Wall Street Journal

Related Articles:
J&J revenue sees first decline in 76 years
J&J's Bill Weldon - CEO Pay
The best of paychecks, the worst of paychecks...


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about Johnson & Johnson   Pharma CEO pay   Bill Weldon   Compensation Package  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.